Cardiac PharmacologyApril 30, 20265 min read

Q-Bank Breakdown: Loop diuretics — Why Every Answer Choice Matters

Clinical vignette on Loop diuretics. Explain correct answer, then systematically address each distractor. Tag: Cardiovascular > Cardiac Pharmacology.

You’re cruising through a cardio pharm block and hit a question that looks like it’s about “which diuretic?”—but it’s really about mechanism, electrolytes, hemodynamics, and side effects. Loop diuretics are a USMLE staple because they show up in CHF, pulmonary edema, hypercalcemia, and drug toxicity vignettes—and the distractors are almost always “near-miss” diuretics or RAAS drugs with overlapping clinical uses.

Tag: Cardiovascular > Cardiac Pharmacology


The Clinical Vignette (Q-bank style)

A 68-year-old man with a history of systolic heart failure (HFrEF) and hypertension presents with acute shortness of breath. He is tachypneic and hypoxic. Exam shows diffuse crackles, elevated JVP, and 2+ pitting edema. Chest X-ray demonstrates pulmonary edema. He is given an IV medication that leads to rapid symptomatic improvement. Shortly afterward, labs show:

  • Na⁺ 138 mEq/L
  • K⁺ 2.9 mEq/L
  • Cl⁻ 96 mEq/L
  • HCO₃⁻ 34 mEq/L
  • Mg²⁺ low

Which drug was most likely administered?

Answer choices: A. Furosemide
B. Hydrochlorothiazide
C. Spironolactone
D. Acetazolamide
E. Mannitol


Step-by-step: Why the Correct Answer is Furosemide (A)

The clinical “tell”

This is acute decompensated heart failure with pulmonary edema. The phrase “IV medication” + “rapid symptomatic improvement” is a classic clue for IV loop diuretics.

Mechanism (must-know)

Loop diuretics (furosemide, bumetanide, torsemide, ethacrynic acid) inhibit the:

  • Na⁺-K⁺-2Cl⁻ (NKCC2) cotransporter in the thick ascending limb of the loop of Henle.

This segment is water-impermeable and is a huge driver of medullary hypertonicity. Blocking NKCC2 causes powerful natriuresis/diuresis → decreased intravascular volume.

The lab pattern

Loop diuretics commonly cause:

  • Hypokalemic metabolic alkalosis
    • Here: K⁺ low and HCO₃⁻ high
  • Hypomagnesemia
  • Increased Ca²⁺ excretion (loops “lose Ca²⁺”)

The immediate hemodynamic benefit

A classic high-yield pearl: IV loop diuretics also cause venodilation (via prostaglandins) → reduced preload quickly, which helps pulmonary edema even before major diuresis kicks in.

💡

USMLE tie-in: If they mention NSAID use blunting the effect, that’s because NSAIDs ↓ prostaglandins → ↓ loop diuretic efficacy.


High-yield Loop Diuretic Facts (memorize-friendly)

Core effects

  • ↑ Na⁺, K⁺, Cl⁻, Mg²⁺ excretion
  • ↑ Ca²⁺ excretion (treat hypercalcemia)
  • ↑ urine output (most potent diuretics)

Indications you’ll see in vignettes

  • Acute pulmonary edema (IV)
  • CHF with volume overload
  • Edema (cirrhosis, nephrotic syndrome)
  • Hypercalcemia
  • Sometimes for HTN when GFR is low (thiazides less effective)

Toxicities (the “OHH DANG” set)

Adverse effectWhy it happens / clue
Ototoxicitydose-related; more likely with aminoglycosides
Hypokalemiaincreased distal Na⁺ delivery → ↑ K⁺ secretion
Hypomagnesemialoss of lumen-positive potential
Dehydrationoverdiuresis
Allergy (sulfa)furosemide/bumetanide/torsemide are sulfonamides
Nephritis (AIN)uncommon but tested

Ethacrynic acid is the loop diuretic to remember when they say: “severe sulfa allergy.” (Also ototoxic.)


Now Destroy the Distractors (B–E)

B. Hydrochlorothiazide — tempting, but wrong for acute pulmonary edema

Why it might lure you: thiazides are diuretics used for hypertension and mild edema.

Why it’s wrong here:

  • Thiazides are less potent and not the go-to for acute pulmonary edema.
  • Mechanism: blocks Na⁺/Cl⁻ cotransporter in the distal convoluted tubule.

High-yield contrast: loops vs thiazides

  • Loops: “lose Ca²⁺” (↑ Ca²⁺ excretion)
  • Thiazides: “save Ca²⁺” (↓ Ca²⁺ excretion) → can cause hypercalcemia

Thiazide side effects you should recognize:

  • Hyponatremia
  • Hypokalemic metabolic alkalosis (yes, also!)
  • HyperGLUC: HyperGlycemia, HyperLipidemia, HyperUricemia, HyperCalcemia

So if the vignette screamed recurrent calcium kidney stones and they want prevention: that’s when HCTZ becomes attractive.


C. Spironolactone — wrong timeline and wrong electrolyte direction

Why it might lure you: it’s used in HF, improves mortality, and is a “diuretic.”

Why it’s wrong here:

  • Not used for rapid symptom relief in acute pulmonary edema.
  • Causes hyperkalemia (this patient has hypokalemia).
  • Much weaker diuresis than loops.

Mechanism:

  • Aldosterone receptor antagonist in the collecting duct → ↓ ENaC and Na⁺ reabsorption → ↓ K⁺/H⁺ secretion.

USMLE HF pearl:

  • Spironolactone/eplerenone are mortality-benefit drugs in HFrEF (along with ACEi/ARB/ARNI, beta blockers, SGLT2 inhibitors, hydralazine/isosorbide dinitrate in select patients).
  • Tested adverse effect: gynecomastia (spironolactone); eplerenone is more selective.

D. Acetazolamide — wrong acid-base pattern

Why it might lure you: it’s a diuretic and changes bicarbonate.

Why it’s wrong here:

  • Acetazolamide causes metabolic acidosis (loss of HCO₃⁻), not alkalosis.
  • It’s not the go-to for pulmonary edema volume removal.

Mechanism:

  • Carbonic anhydrase inhibitor in the proximal tubule → ↓ HCO₃⁻ reabsorption → alkaline urine, acidic blood.

Classic indications:

  • Altitude sickness
  • Glaucoma
  • Idiopathic intracranial hypertension
  • Metabolic alkalosis correction (sometimes)

Side effects to recall:

  • NAGMA metabolic acidosis
  • Hypokalemia
  • Kidney stones (↑ urine pH)
  • Sulfa allergy risk

E. Mannitol — would worsen pulmonary edema

Why it might lure you: osmotic diuretic, increases urine output.

Why it’s wrong here:

  • Mannitol initially expands intravascular volume by pulling water into the bloodstream → can worsen pulmonary edema and CHF.
  • It’s used more for reducing intracranial pressure and intraocular pressure.

Mechanism:

  • Osmotic diuretic filtered at the glomerulus, not reabsorbed → holds water in the tubule.

Board-style contraindication clue:

  • If the patient has CHF or pulmonary edema, mannitol is dangerous.

The “Answer Choice Matters” Takeaways (what to remember on test day)

If you see acute pulmonary edema in CHF

Think:

  • IV loop diuretic (e.g., furosemide) for rapid decongestion
  • Expect hypokalemic metabolic alkalosis and hypomagnesemia

If you see recurrent calcium stones

Think:

  • Thiazide (↓ urinary Ca²⁺)

If you see HFrEF mortality benefit + hyperK risk

Think:

  • Spironolactone/eplerenone

If you see altitude sickness / glaucoma / IIH

Think:

  • Acetazolamide (metabolic acidosis)

If you see increased ICP but NOT CHF

Think:

  • Mannitol (watch for pulmonary edema)

Rapid-Fire Table: Diuretics at a Glance (USMLE favorite)

Drug classSiteAcid-baseK⁺ effectSignature clinical clue
Loop (furosemide)Thick ascending limb (NKCC2)Metabolic alkalosis↓ K⁺Pulmonary edema, hypercalcemia, ototoxicity
Thiazide (HCTZ)DCT (Na⁺/Cl⁻)Metabolic alkalosis↓ K⁺Hypercalcemia, gout, hyperglycemia
K⁺-sparing (spironolactone)Collecting ductMild acidosis tendency↑ K⁺Gynecomastia, mortality benefit in HFrEF
CA inhibitor (acetazolamide)PCTMetabolic acidosis↓ K⁺Altitude sickness, glaucoma, kidney stones
Osmotic (mannitol)PCT/descending limbVariableVariable↑ ICP/IOP; worsens CHF/pulm edema